Sagittal image from a transvaginal sonogram in a patient with bleeding after a spontaneous abortion. The endometrium (between cursors) was thick and heterogeneous, measuring 8.5 mm in thickness (Fig1). Color doppler image in same patient shows focal flow (Fig. 2 - arrow) within the heterogeneous endometrium.
Title of Image: Retained Products of Conception
Description of Image: Sagittal image from a transvaginal sonogram in a patient with bleeding after a spontaneous abortion. The endometrium (between cursors) was thick and heterogeneous, measuring 8.5 mm in thickness (Fig1). Color doppler image in same patient shows focal flow (Fig. 2 - arrow) within the heterogeneous endometrium. Subsequent dilatation and evacuation (D&E) revealed retained products of conception (RPOC). The endometrial thickness may be useful to evaluate for RPOC. If the endometrium is very thin, RPOC are unlikely. A thicker endometrium is more likely to contain products of conception (Fig 1). Unfortunately, it is unclear what endometrial thickness measurement best distinguishes patients without and with RPOC. When endometrial thickness is less than 10 mm, clinically significant RPOC are reported to be unlikely. Another study reported 100% sensitivity and 80% specificity for RPOC using an endometrial thickness cutoff of 8 mm. The presence of detectable flow by Doppler ultrasound within an endometrial mass or in a thickened endometrium seems to be more indicative of RPOC (Fig 2), whereas absence of flow may favor clot. We use Doppler ultrasound, but do not fully rely on it.
Click Images to enlarge
Add your comments to this interactive case study.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More